TB in Special Populations:
Across the Lifespan
Friday, June 11, 2021 *  3:00 PM – 5:00 PM Eastern Time
Treating tuberculosis (TB) is a different journey for each patient and care team. Age is one of the factors that can increase TB risk and complicate its treatment.
  • How can pregnancy affect the presentation, treatment, and management of TB?
  • How should the clinician test and treat neonates and children under 5 years old?
  • What complications surround the treatment and management of elderly patients with TB?
This session will focus on TB in some of the most vulnerable and difficult to treat populations: pregnant women, neonates, children <5 years of age, and the elderly. Presentations will provide a variety of perspectives from that of a TB survivor who was pregnant when diagnosed to unique challenges presented to clinicians and nurses by the incredibly young and older patient populations.
About the Faculty

Lisa Armitige, MD, PhD

Dr. Armitige is an Associate Professor of Infectious Diseases, Internal Medicine and Pediatrics at the University of Texas Health Sciences Center at Tyler. She serves on the staff of Heartland National TB Center as the Assistant Medical Director and is currently Co-Medical Director of the San Antonio, Texas TB clinic. In these capacities, she lectures nationally and internationally on tuberculosis and cares for both adult and pediatric patients with TB at a large metropolitan clinic. Dr. Armitige was previously at the McGovern Medical School in Houston where she did her residency in Med/Peds and a fellowship in ID and served as faculty there caring for both TB- and human immunodeficiency virus (HIV)-infected patients. In addition to participating in clinical studies involving treatment shortening regimens for latent TB infection (LTBI), Dr. Armitige conducts biomedical research in the pathogenesis of TB. See Dr. Armitige's publications on PubMed.

Kate O'Brien
Kate O’Brien is a TB survivor and advocate with a background in TV production and marketing. Kate was treated for active pulmonary disease in 2015 when pregnant. Kate currently works on TB patient support and community engagement through We Are TB, a TB survivor advocacy organization supported by NTCA. Kate is a member of the STOP TB Community Delegation and the Union’s Community Advisory Panel. Passionate about leaving behind a TB-free world for her children, Kate was named a "CDC TB Elimination Champion" in 2019.

Jyoti Mathad, MD, MSc
Dr. Jyoti Mathad is an Assistant Professor of Medicine and Obstetrics and Gynecology in the Center for Global Health at Weill Cornell Medicine in New York. She is trained in infectious diseases and her research focuses on the immune and metabolic changes of pregnancy and their impact on the pathogenesis of infectious diseases, especially TB. She led the PRACHITi study in India, investigating the impact of pregnancy and HIV on the immune response to M. tuberculosis. She also chaired IMPAACT 2001, a multi-country study on the pharmacokinetics, tolerability, and safety of the 3HP regimen in pregnant and postpartum women. See Dr. Mathad's publications on PubMed.

Of special note to this session, Dr. Mathad consulted on Kate O’Brien’s TB diagnosis and treatment while pregnant. We are fortunate to have a survivor-physician dyad for this session and recognize what a powerful experience for them, and for all conference participants, to have them appear together at a national conference!  

Michelle Haas, MD
Dr. Michelle Haas is an Assistant Professor of Infectious Diseases and the Associate Director for the Denver Metro Tuberculosis Program. She is also an Assistant Professor of Medicine within the Division of Infectious Diseases at the University of Colorado-Anschutz Medical Campus.
Dr. Haas’s role is to provide oversight to the management of active and latent TB and consultative support for the Colorado TB Program. She is a member of the Curry Center Warmline faculty, a member of the Tuberculosis Trials Consortium and is also a member of the Tuberculosis Epidemiologic Studies Consortium. For the past year, she has also served as the Secretary for the National Society of TB Clinicians.  
Her TB programmatic interests are: 1) improving access and retention in care for individuals with TB infection and disease, 2) optimizing treatment regimens for latent and active TB 3) improving treatment outcomes for older adults with latent and active TB. See Dr. Haas's publications on PubMed.

Masa Narita, MD
Dr. Masa Narita is the Seattle & King County’s TB Control Officer and a Professor of Medicine in the Division of Pulmonary, Critical Care, and Sleep Medicine, University of Washington. He received TB training under the mentorship of Dr. Dave Ashkin. He has been directing Seattle & King County’s TB control program since 2002.  
2021 National TB Conference
Explore cutting-edge TB clinical and programmatic content and get a jump start on caring for your patients with TB. 
NTCA is partnering with the University of New Mexico’s School of Medicine’s Office of Continuing Medical Education and Eastern New Mexico University to provide continuing education credits for the Virtual 2021 NTC. If you cannot attend a session on its original broadcast date, you still can earn credit by watching its video recording at a later date. Video recordings of the session will be available for enduring credits for up to a year.
Earn two AMA PRA Category 1 credits™ per educational session or 22 total credits for the whole conference. Earn two nursing continuing education hours per educational session or 22 total hours for the whole conference.
Participant Registration
It's not too late to register!

The registration fees for the Virtual 2021 NTC are listed below. This year, we've added a discounted fee for our retired colleagues and for students in any health-related program.
  • NTCA Member - $150.00
  • NTCA Non-Member - $250.00
  • Retirees or Students - $75.00
Conference registration fees can be paid by credit card, check, or ACH deposit.
Exhibitor and Sponsorship Infomation
The exhibit and sponsorship fees for the Virtual 2021 NTC are listed below. 

  • Virtual Exhibit Booth - $1,000
  • Silver - $5,000
  • Gold - $10,000
  • Platinum - $15,000
If you are interested in learning more about the exhibit and sponsorship opportunities of the Virtual 2021 NTC, please email Donna Hope Wegener at dhwegener@tbcontrollers.org or call 678-503-0503.
Sherry Brown, NTCA: sbrown@tbcontrollers.org
Donna Wegener, NTCA: dhwegener@tbcontrollers.org